NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gabriel S. MorrisCFO2025-12-10770$6.58
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-12-10746$6.67
$4.98kBuy
Gabriel S. MorrisCFO2025-12-08156,000$0.80
$124.80kBuy
Ilya M. RachmanCEO and Chairman2025-09-172,500$2.02
$5.05kBuy
Gabriel S. MorrisCFO2025-09-162,600$1.97
$5.12kBuy
Gabriel S. MorrisCFO2025-06-182,225$2.28
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-06-182,178$2.30
$5.00kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC7.40%3,921,568$37.49MInstitution
Yekaterina Chudnovsky6.12%3,241,076$30.98MInsider
Saturn V Capital Management LP5.66%2,999,169$28.67MInstitution
Eventide Asset Management LLC4.81%2,549,019$24.37MInstitution
Marshall Wace LLP3.74%1,978,743$18.92MInstitution
Millennium Management LLC3.13%1,659,778$15.87MInstitution
Adage Capital Partners GP LLC2.83%1,500,000$14.34MInstitution
Ilya M. Rachman2.16%1,141,683$10.91MInsider
Vanguard Group Inc2.07%1,095,814$10.48MInstitution
Carey Ng1.97%1,045,221$9.99MInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX46.04%18.30%Net Buying
MDXG46.84%53.16%Net BuyingNet Buying
TECX26.30%73.70%Net BuyingNet Selling
EIKN0.00%24.62%Net Buying
CTNM79.11%7.17%Net SellingNet Selling

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 46.04% institutional shareholders, 18.30% IMMIX Biopharma insiders, and 35.66% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 6.12% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $33.45M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.